Clinical Trials Browser

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT01511562 2026-01-30

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Phase 2 Active not recruiting

113 enrolled 14 charts

Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02896582 2026-01-14

LyMa101

Phase 2 Completed

86 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT04871607 2025-12-04

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

Phase 2 Recruiting

33 enrolled

Lymphoid

Hodgkin Disease

NCT02570542 2025-11-26

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase 2 Active not recruiting

59 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05052957 2025-11-21

hSTAR GBM

Phase 2 Recruiting

16 enrolled

CNS

Glioblastoma

NCT03125642 2025-11-04

Auto Stem Cell Transplant for Lymphoma Patients

Phase 2 Recruiting

150 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01908777 2025-10-09

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Phase 2 Completed

47 enrolled

Lymphoid

Lymphoma, T-Cell

NCT07199296 2025-09-30

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

Phase 2 Recruiting

45 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT02329080 2025-07-08

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

Phase 2 Completed

79 enrolled 26 charts

Lymphoid

Lymphoma, Large B-Cell, Diffuse

Clinical Trials

TEMOBIC

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

CNS-PHLAT

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

LyMa101

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

hSTAR GBM

Auto Stem Cell Transplant for Lymphoma Patients

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement